// App-Quantinova.ai

1979 : Tc99m Tilmanocept Imaging Can Differentiate the Fibroid Pathotype of Rheumatoid Arthritis from Non-Fibroid Pathotypes in Patients

Researchers

Presenter

  • Costantino Pitzalis

Principal Investigators

  • rebecca hands

  • Swamy Venuturupalli

  • Ami Ben-artzi

  • Eric Ruderman

  • Harris Perlman

  • Arthur Mandelin

  • Mara Leach

  • Addison Hasselbach

  • Bonnie Abbruzzese

  • Rachael Hershey

  • Beth Potter

  • Jessica Fitzpatrick

  • Aaron Thornton

  • Michael Blue

  • Jonathan Graf

  • David Ralph

  • Michael Rosol

Medical Centers

  • Northwestern University, Chicago, IL

  • Queen Mary University of London, London, United Kingdom

  • Northwestern University, Feinberg School of Medicine, Chicago, IL

  • William Harvey Research Institute, London, United Kingdom

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • UCSF, San Francisco, CA

  • Navidea Biopharmaceuticals, Dublin, OH

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Technetium tc 99m tilmanocept

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • II

Study Id's

  • NCT04078191

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved